Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $43 | $51 | $48 |
| Short-Term Investments | $158 | $155 | $143 | $174 |
| Receivables | $46 | $44 | $44 | $42 |
| Inventory | $10 | $8 | $9 | $8 |
| Other Curr. Assets | $12 | $11 | $11 | $11 |
| Total Curr. Assets | $281 | $262 | $256 | $284 |
| Property Plant & Equip (Net) | $79 | $84 | $88 | $94 |
| Goodwill | $119 | $119 | $119 | $119 |
| Intangibles | $2 | $3 | $3 | $3 |
| Long-Term Investments | $7 | $24 | $39 | $34 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $5 | $5 | $5 |
| Total NC Assets | $209 | $235 | $254 | $256 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $491 | $497 | $511 | $539 |
| Liabilities | – | – | – | – |
| Payables | $10 | $7 | $6 | $7 |
| Short-Term Debt | $12 | $10 | $10 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $41 | $55 | $55 | $56 |
| Other Curr. Liab. | $20 | $20 | $16 | $25 |
| Total Curr. Liab. | $83 | $92 | $88 | $98 |
| LT Debt | $202 | $74 | $76 | $79 |
| Deferred Rev, NC | $1 | $20 | $25 | $27 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $131 | $132 | $132 |
| Total NC Liab. | $203 | $225 | $233 | $239 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $72 | $84 | $87 | $89 |
| Total Liabilities | $286 | $317 | $321 | $337 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,350 | -$1,359 | -$1,334 | -$1,304 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,554 | $1,539 | $1,524 | $1,506 |
| Total Equity | $204 | $180 | $190 | $203 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $491 | $497 | $511 | $539 |
| Net Debt | $159 | $41 | $36 | $41 |